Long-acting β2-agonists in the treatment of acute exacerbations of COPD

Clinical Drug Investigation

Volumn 22, Issue 6, 2002, Pages 369-376

  Cazzola, Mario ^a   Matera, Maria G ^b   D’Amato, Maria ^b   Noschese, Paolo ^a   Califano, Clara ^a   Di Perna, Felice ^a   Terzano, Claudio ^c   D’Amato, Gennaro ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; FLUTICASONE; FORMOTEROL; LEVOFLOXACIN; SALMETEROL; STEROID;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HEART PALPITATION; HEART RATE; HUMAN; INSPIRATORY CAPACITY; MALE; METERED DOSE INHALER; OUTPATIENT DEPARTMENT; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREMOR;

EID: 0036285311     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222060-00004     Document Type: Article

References (32)

1. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease
2. Management of acute exacerbations of COPD
3. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD
4. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction
5. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
6. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
7. Toward a consensus definition for COPD exacerbations
8. BTS guidelines for the management of chronic obstructive pulmonary disease
9. Standardization of spirometry: 1987 Update
10. β-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease
11. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
12. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action
13. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: A dose-response study
14. The use of bronchodilators in stable chronic obstructive pulmonary disease
15. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease
16. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus
17. Adverse reactions to β2-agonistbronchodilators
18. Effects of a pretreatment with conventional doses of formoterol, salmeterol or oxitropium bromide on the dose-response curves to salbutamol in patients suffering from partially reversible COPD
19. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma
20. Fenoterol and ipratropium bromide for treatment of patients with chronic bronchitis
21. Physician estimation of FEV 1 in acute exacerbation of COPD
22. Beta-adrenergic receptors in congestive heart failure: Present knowledge and future directions
23. The pharmacology of salmeterol
24. Formoterol as dry powder inhalation: A dose finding study in comparison with formoterol metered dose inhaler and placebo
25. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: Comparison with salbutamol in adult asthmatic patients
26. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia
27. An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects
28. Ventilation-perfusion changes after aerosolized isoproterenol in asthma
29. Ventilation-perfusion inequality in asymptomatic asthma
30. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease comparison with albuterol and ipratropium
31. Oximetry-know thy limits